Feasibility and Safety of Robotic Peripheral Vascular Interventions

Self Cite

The feasibility, safety, and high technical success of robotically assisted percutaneous coronary intervention (PCI) for the treatment of both simple and complex coronary disease has been demonstrated. As the current generation robotic platform is limited to a rapid exchange system, orbital or rotational atherectomy cannot be performed robotically. However, excimer laser coronary atherectomy is performed with a rapid exchange catheter but its feasibility during robotically assisted PCI is unknown. We report the successful use of laser atherectomy during two complex robotically assisted PCI procedures using the CorPath GRX robotic system.

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Robotically performed excimer laser coronary atherectomy: Proof of feasibility

Almasoud

Walters

Mahmud

2018

Self Cite

“…The RAPID (Robotic‐Assisted Peripheral Interventions for Peripheral Artery Disease) trial, a prospective single center, safety and feasibility study demonstrated the utility of the CorPath 200 system for robotic PVI. Patients with symptomatic PAD affecting the femoro‐popliteal artery due to either lifestyle limiting claudication or critical limb ischemia requiring PVI were enrolled . The objective of this study was to examine the CorPath 200 performance at delivering guidewires and balloons to the identified lesions.…”

Section: The Systemsmentioning

confidence: 99%

Robotic technology in interventional cardiology: Current status and future perspectives

Mahmud

Pourdjabbar

Ang

et al. 2017

Self Cite

Robotic technology has been utilized in cardiovascular medicine for over a decade, and over that period, its use has been expanded to percutaneous coronary and peripheral vascular interventions. The safety and feasibility of robotically assisted percutaneous cardiovascular interventions has been demonstrated in studies including simple to complex coronary lesions, and both iliac and femoropopliteal lesions. These reports have shown that robotically assisted PCI significantly reduces operator exposure to harmful ionizing radiation without a detrimental effect on procedural success or clinical efficacy. Additionally, the use of robotics has the intuitive benefit of alleviating the risk of orthopedic injuries faced by interventional operators. In addition to the interventional operator benefits, robotically assisted intervention has the potential for patient level benefit by allowing more accurate lesion length measurement, precise stent placement, and lower patient radiation exposure. However, further investigation is required to fully elucidate these potential benefits.

“…Lastly, the robotic‐assisted PCI system has demonstrated success with peripheral artery disease (PAD) . In the RAPID trial, Mahmud et al investigated the CorPath 200 system in 20 patients with Rutherford class 3–5 PAD involving the femoropopliteal artery.…”

Section: Outcomes Of the Robotic‐assisted Pci Systemmentioning

confidence: 99%

Robotic‐assisted percutaneous coronary intervention

Mangels

Giri

Hirshfeld

et al. 2017

Performance of percutaneous coronary intervention (PCI) is associated with several occupational hazards including radiation exposure and musculoskeletal injury. Current methods to mitigate these risks range from suspended radiation suits to adjustable lead-lined glass shields. Robotic-assisted PCI is a novel approach to PCI that utilizes remote-controlled technology to manipulate catheters thereby significantly reducing radiation exposure to the operator and catheterization laboratory staff. Although limited, current evidence indicates that robotic-assisted PCI is associated with a high technical success rate and may have additional advantages over conventional PCI, such as a decreased incidence of geographical miss. However, as the technology is nascent, further studies including larger, randomized controlled trials are needed to expand on the long-term clinical and safety outcomes.